Blue Jet Healthcare (MAINBOARD)
Oct 25, 2023 - Oct 27, 2023
| Price | ₹329 - ₹346 |
| Premium | ₹22 |
|---|---|
| Lot size | 43 |
| Allotment | Oct 30, 2023 |
| Listing | Nov 1, 2023 |
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 43 | 14878 | 197670 |
| sHNI | 14 | 602 | 208292 | 2017 |
| bHNI | 68 | 2924 | 1011704 | 4034 |
Last Updated as on 27-Oct-2023 17:00:00
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 48,57,032 | 6,66,51,247 | 13.72 |
| HNIs | 36,42,774 | 4,94,99,708 | 13.59 |
| HNIs (10+L) | 24,28,516 | 3,80,08,044 | 15.65 |
| HNIs (2-10L) | 12,14,258 | 1,14,91,664 | 9.46 |
| Retail | 84,99,806 | 1,88,95,533 | 2.22 |
| Total | 1,69,99,612 | 13,50,46,488 | 7.94 |
Incorporated in 1968, Blue Jet Healthcare is a pharmaceutical and healthcare ingredient and an intermediate company. Blue Jet Healthcare was the first manufacturer of saccharin and its salts (artificial sweeteners) in India.They later expanded into contrast media intermediates, which are used in CT scans and MRIs. The company mainly deals in three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients.
- Process development and production capabilities
- Global regulatory support
- Collaboration, development, and manufacturing of advanced pharmaceutical intermediates and API.
The company has three manufacturing facilities, which are situated in Shahad (Unit I), Ambernath (Unit II) and Mahad (Unit III) in the state of Maharashtra, India, with an annual installed capacity of 200.60 KL, 607.30 KL and 213.00 KL, respectively, as of June 30, 2023.
Company's core strength lies in the following
- Huge manufacturing capacity of contrast media intermediates in India.
- The company operates in a niche market that has high entry barriers.
- Long-term relationships and long term contracts with multi-national customers.
Blue Jet Healthcare IPO Details
| Issue Size | 840 Cr Approx |
| Offer for Sale | 24,285,160 shares of ₹2 (aggregating up to ₹[840] Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 173,465,425 |
| Share holding post issue | 173,465,425 |
Blue Jet Healthcare IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Company Financials
Blue Jet Healthcare Limited Financial Information (Restated)
Blue Jet Healthcare Limited's revenue increased by 5.98% and profit after tax (PAT) dropped by -11.88% between the financial year ending with March 31, 2023 and March 31, 2022.
| Period | 30 Jun 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
| Assets | 903.80 | 862.07 | 713.38 | 536.27 |
| Revenue | 184.60 | 744.94 | 702.88 | 507.81 |
| Profit | 44.12 | 160.03 | 181.59 | 135.79 |
| Net Worth | 725.68 | 681.49 | 521.54 | 339.82 |
| Reserves | ||||
| Borrowing | ||||
| Amount in ₹ Crore | ||||
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: bluejet.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html